Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis
2006-006465-16Phase 2Completed
- Sponsor
- Leipzig University
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of somatropin in multiple sclerosis (MS) (2 arms), sponsored by Leipzig University. Primary endpoint: Cumulative number of active brain MRI lesions. Started May 2007; status: completed.
02
Drugs
somatropin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-006465-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006465-16.